Michelle Laspaluto

Michelle Laspaluto is currently the VP of Strategic Planning and Investor Relations at Chimerix. Michelle has over 15 years of experience in the finance industry. Prior to their current position, Michelle was the Sr. Dir of Finance at AlphaVax from May 2000 to June 2011. Before that, they were a Sr. Associate at PwC from January 1996 to May 2000. Michelle has a proven track record in the finance industry and is an expert in their field.

Michelle Laspaluto earned a Bachelor of Arts in Accounting from Michigan State University and a Master of Business Administration from East Carolina University.

Michelle Laspaluto reports to Mike Sherman, President & CEO . They are on a team with Odin Naderer - Vice President, Clinical Pharmacology and Translational Medicine, Roy W. Ware - Chief Manufacturing and Technology Officer, and Heather Knight-Trent - Vice President of Regulatory Affairs.